Clinical trials
Oncology clinical trials
Below are recruiting oncology clinical trials, each written for real people, not researchers. We’re tracking 797 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07225491Recruiting
Spine cancer treatment study
This study collects information about people with spine cancer who have surgery to relieve pressure on the spine, followed by radiation therapy. The goal is to learn more about how well these treatments work together.
Indianapolis, IndianaAges 18 years+ - NCT06756607Recruiting
Helping more Black and Latino patients join cancer trials
This study tests a new program to make it easier for Black and Latino people with cancer to join clinical trials. Your participation can help researchers learn how to improve access for everyone.
Jonesboro, ArkansasAges 18 years+ - NCT07441681RecruitingPhase 3
Comparing radiation plus targeted therapy vs standard chemo for head and neck cancer
This trial compares two treatments for advanced head and neck cancer in patients who cannot take the drug cisplatin. One group gets radiation plus a targeted drug called cetuximab, the other gets radiation plus standard chemotherapy. The goal is to see which approach works better and is safer for people who are not candidates for cisplatin.
Beverly Hills, CaliforniaAges 18 years+ - NCT06800053Recruiting
Support for LGBTQ+ cancer patients and caregivers
This study tests the FOCUS program, a support program designed for sexual and gender minority (LGBTQ+) cancer patients and their unpaid caregivers. It aims to help patients and caregivers cope with cancer through education and emotional support.
Detroit, MichiganAges 18–100 - NCT07765927Recruiting
Exercise program for people with breast or gynecologic cancer
This study is testing whether an exercise program for people with breast or gynecologic cancer is feasible to run. It aims to see if patients can participate and follow the program.
Iowa City, IowaAges 18 years+ - NCT07007559RecruitingPhase 2
Evorpacept with trastuzumab and chemo for HER2-positive breast cancer
This study tests an experimental drug called evorpacept when given with trastuzumab and chemotherapy for people with HER2-positive breast cancer that has spread. The goal is to see if this combination can shrink tumors or slow down the cancer.
Tucson, ArizonaAges 18 years+ - NCT06822543RecruitingPhase 2
A new treatment for lung cancer that has spread to the brain
This trial tests a combination of three drugs (datopotamab deruxtecan, carboplatin, and pembrolizumab) for people with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to the brain and has not been treated before. The goal is to see if this combination can shrink tumors in the brain and elsewhere.
Fortaleza, CearáAges 18 years+ - NCT07764276Recruiting
Enhanced recovery after gynecologic surgery
This study looks at whether a structured program to speed up recovery after major gynecologic surgery helps patients feel better and leave the hospital sooner. It focuses on women having open (laparotomic) surgery for conditions like fibroids, ovarian cysts, or cancer.
HsinchuAges 18 years+ - NCT07761871Recruiting
Exercise and diet for people with melanoma on immunotherapy
This trial looks at whether adding a program of exercise and nutrition changes can improve quality of life and treatment outcomes for people with melanoma who are starting immunotherapy. If you qualify, you would take part in a structured plan to see if these lifestyle changes help.
LjubljanaAges 18 years+ - NCT07759999Recruiting
Proton therapy planning software study
This study tests a new software system used to plan and manage proton therapy, a type of radiation treatment that targets tumors precisely. It aims to see if the software works well in routine care, which could improve treatment for future patients.
Madison, WisconsinAges 18 years+ - NCT02290522Recruiting
Personalized cancer treatment study
This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.
CopenhagenAges 18 years+ - NCT07288112RecruitingPhase 1/Phase 2
Personalized immune vaccine for advanced melanoma
This trial tests a new personalized vaccine made from your own tumor cells. It's for people with advanced melanoma that hasn't responded to standard immunotherapy. The goal is to see if this vaccine can help your immune system fight the cancer.
Birmingham, AlabamaAges 18 years+ - NCT05706129RecruitingPhase 1/Phase 2
Testing targeted imaging and therapy for advanced solid tumors
This early-phase study tests two radioactive medicines that first help doctors see tumors and, in some parts of the study, treat them. It may help people with advanced, hard-to-remove cancers that have a specific tumor marker (CA IX).
MelbourneAges 18 years+ - NCT07672314Recruiting
Psychosocial support study for cancer survivors
This study tests a program to help cancer survivors manage emotional and social challenges after treatment. You may be able to join if you have completed your main cancer treatment and are now in routine follow-up care.
BaselAges 18 years+ - NCT06580314RecruitingPhase 3
Olaparib with or without bevacizumab for ovarian cancer
This trial tests whether taking the drug olaparib for one or two years, alone or with another drug called bevacizumab, can help keep ovarian cancer from coming back after initial chemotherapy and surgery. It is for people with certain genetic markers in their tumor.
Birmingham, AlabamaAges 18 years+ - NCT04251052Recruiting
Compare two surgeries to lower ovarian cancer risk in BRCA1 carriers
This study compares two risk-reducing surgery plans for people with a BRCA1 genetic change to see which approach helps lower ovarian cancer risk. You may be asked to have the study procedure sooner or later depending on your chosen plan.
Birmingham, AlabamaAges 35–50 - NCT07380672Recruiting
Relaxation and hypnosis for anxiety after childhood cancer
This study tests whether hypnosis and relaxation exercises can help lower anxiety in kids, teens, and young adults who finished cancer treatment. If you often feel anxious after your cancer journey, you might be able to join and learn new ways to feel calmer.
CaenAges 7–25 - NCT05646316RecruitingPhase 3
Sentinel lymph node mapping to reduce leg swelling after surgery
This study tests whether a special way of finding lymph nodes during hysterectomy can lower the risk of long-term leg swelling or related dysfunction in people with stage I endometrial cancer. It compares standard lymph node assessment with sentinel lymph node mapping and looks at how this affects day-to-day leg functioning.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06240559Recruiting
Brachytherapy treatment verification study
This study checks if doctors can better verify brachytherapy (a type of internal radiation) during treatment for gynecological or prostate cancer. It may help improve accuracy and outcomes for patients receiving this therapy.
Maastricht, LimburgAges Any age - NCT04293796Recruiting
Skipping breast surgery after complete response
This trial looks at whether some people with breast cancer can safely avoid breast surgery after they respond completely to treatment before surgery. If you have no remaining cancer in the tissue and lymph node tests, this study checks whether the “watch-and-wait” approach is feasible and safe.
Saint PetersburgAges 18–70 - NCT07731880Recruiting
SmartMatch Study for Rare Gynecologic Cancers
This study tests a new approach called SmartMatch that looks at the unique traits of your tumor to find the best treatment for you. The goal is to see if this personalized approach is feasible and helpful for people with rare gynecologic cancers.
Seattle, WashingtonAges 18 years+ - NCT05976763RecruitingPhase 3
Testing continuous vs. intermittent zanubrutinib for older adults with mantle cell lymphoma
This trial tests whether taking the targeted drug zanubrutinib continuously is better than taking it on a schedule with breaks for older adults with untreated mantle cell lymphoma. The goal is to find a treatment that works while reducing side effects.
Little Rock, ArkansasAges 60 years+ - NCT07343297Recruiting
Ask questions about clinical trials
This study helps people learn about clinical trials and find out if they might be a good fit. It is for patients who are already getting treatment at a Karmanos or McLaren center and can read English well enough to complete surveys.
Bay City, MichiganAges 18 years+ - NCT07279571Recruiting
AI chatbot education for gynecologic cancer patients
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for oncology?
- Yes. Clin2 currently lists 797 recruiting oncology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a oncology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a oncology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.